
About Apotex Research Private Limited
Data last updated:
Apotex Research Private Limited is a private limited company based in Jigani Hobli, Karnataka, India, a subsidiary of Apotex Pharmaceuticals Holdings Inc.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2003PTC032103. Its GSTIN is 29AAECA2791B1ZU (Karnataka). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹460 Cr and a paid-up capital of ₹291.86 Cr. It is led by directors including Brian George Mcclelland and Goutam Vilas Pujari.
Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Site No.1 Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Jigani Hobli, Karnataka, India – 562158.
As per the financials filed for FY 2025, the company reported a revenue of ₹727.34 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹76.62 Cr (net margin 10.5%) and EBITDA of ₹148.77 Cr (EBITDA margin 20.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 931% over five years.
The company has about 1,367 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Apotex Pharmachem India and Apotex. As per MCA filings, the company has open charges of ₹483.8 Cr on record. Court records list 19 cases involving the company, including 10 filed by the company and 9 filed against it; 2 cases are pending. The company has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹272.33 Cr; the latest was in March 2025. The company has 12 MSME Form 1 returns on record between 2016 and 2024, listing 120 overdue payments to 50 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apotex.com.
Company details
Contact details
Apotex Research Private Limited's registered office is in Jigani Hobli, Karnataka. Its website is apotex.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSite No.1 Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Jigani Hobli, Karnataka, India – 562158
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Apotex Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Apotex Research operates two associated brands: Apotex Pharmachem India and Apotex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. | apotex.co.in | |
| Generic pharmaceutical formulations are manufactured and exported by Apotex globally. | apotex.com |
Business activity
The main business activities of Apotex Research are manufacturing and professional, scientific and technical. In detail, this covers manufacture of chemicals and chemical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Apotex Research Private Limited, buy the company report.
Financials of Apotex Research Private Limited
FY 2025 filings availableApotex Research Private Limited reported revenue of ₹727.34 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 931% over five years, including 22% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹727.34 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹148.77 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹76.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.5% | ||||
| Net Profit Margin | 10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apotex Research Private Limited, buy the company report.
Board of directors of Apotex Research Private Limited
Apotex Research has 4 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brian George Mcclelland Also directs: Apotex Pharmachem India Private Limited | Director | 15 Sep 2023 | 3 Years 2 Months | Current |
| Rajesh Salwan | Additional Director | 18 Mar 2025 | 1 Years 8 Months | Current |
| Goutam Vilas Pujari | Director | 01 Dec 2018 | 7 Years 11 Months | Current |
| Uta Kellermann Renton Also directs: Apotex Pharmachem India Private Limited | Additional Director | 18 Mar 2025 | 1 Years 8 Months | Current |
Auditor
Apotex Research Private Limited is audited by Haribhakti & Co. LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Haribhakti & Co. LLP | FY 2025 | 103523W/W100048 |
Shareholding
The shareholding of Apotex Research Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apotex Research Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2023 | 100801520 | Others | ₹30 Cr | Open | |
| 09 Jun 2017 | 100107924 | Others | ₹5 Cr | Open | |
| 24 Mar 2016 | 100017935 | The Hongkong and Shanghai Banking Corporation Limited | ₹80 Lakh | Open | |
| 17 Oct 2012 | 10381903 | The Hongkong and Shanghai Banking Corporation Limited | ₹198 Cr | Open | |
| 31 Mar 2006 | 10004034 | Apotex Pharmaceutical Holdings Inc | ₹250 Cr | Open |
To see the full charge records of Apotex Research Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Apotex Research Private Limited has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹272.33 Cr; the latest was in March 2025.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: Apotex Inc, Ontario Inc Seller: Apotex Pharmaceutical Holdings Inc, Apotex Pharmachem Inc |
| Apr 2011 | Funding round | ₹207.64 Cr | Investors: Apotex Pharmaceutical Holdings Inc |
| Mar 2009 | Funding round | ₹36.24 Cr | Investors: Apotex Pharmaceutical Holdings Inc |
| Jul 2007 | Funding round | ₹28.45 Cr | Investors: Apotex Pharmaceutical Holdings Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Apotex Research Private Limited has 19 court cases on record: 10 filed by Apotex Research, 9 filed against it. 2 cases are pending and 17 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 4 | 0 |
| District courts | 3 | 3 | 1 |
| Supreme Court | 3 | 2 | 1 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against Government of Karnataka | Disposed |
| District court, BENGALURU RURAL, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed by the company against The Additional Commissioner of Commercial Taxes and 2 others | Pending |
| Supreme Court | Court case (0303-Direct Taxes Matter : Other matters under Income Tax act, 1961) | Filed against the company by The Commissioner of Income Tax Cit (A) the Commissioner of Income Tax Cit (A) CR Building Queens Road , District: Bangalore ,Bangalore , Karnataka and 1 other | Disposed |
| High Court, KARNATAKA | Court case (STA) | Filed by the company against The Addl. Commissioner of Commerical Taxes | Disposed |
To see the full case history of Apotex Research Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Apotex Research Private Limited has 12 MSME Form 1 returns on record between 2016 and 2024, listing 120 overdue payments to 50 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 50)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Mokshy Surgical | |||
| an individual supplier | |||
| an individual supplier | |||
| Esskay Compuservices Private Limited | |||
| Asian Filtration Technology |
To see the full MSME payment records of Apotex Research Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Apotex Research Private Limited has a workforce of 1,367 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 1,367 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Apotex Research Private Limited, buy the company report.
GST
Apotex Research has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECA2791B1ZU | Karnataka | Active | 01 Jul 2017 |
| 29AAECA2791B2ZT | Karnataka | Active | 21 Mar 2025 |
| 27AAECA2791B1ZY | Maharashtra | Active | 09 Aug 2017 |
To see the full GST registrations and return filing status of Apotex Research Private Limited, buy the company report.
Recent activity
Apotex Research Private Limited has 17 board changes on record since 2015: 5 appointments and 12 cessations. The latest: Rajesh Salwan was appointed as Additional Director on 18 Mar 2025.
16 earlier events are in the company report.
News
Frequently asked questions
Apotex Research is an active private limited company based in Jigani Hobli, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 June 2003 (23+ years old) and is registered under CIN U73100KA2003PTC032103.
Apotex Research has 4 current directors:
- Brian George Mcclelland - Director
- Rajesh Salwan - Additional Director
- Goutam Vilas Pujari - Director
- Uta Kellermann Renton - Additional Director
The latest financial statements of Apotex Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Apotex Research is 29AAECA2791B1ZU, registered in Karnataka. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 29AAECA2791B2ZT (Karnataka), 27AAECA2791B1ZY (Maharashtra).
The CIN (Corporate Identification Number) of Apotex Research is U73100KA2003PTC032103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apotex Research has 19 court cases on record: 10 filed by the company and 9 filed against it. 2 are pending. Most are in the high courts.
Apotex Research was incorporated on 16 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Bangalore.
Apotex Research has 4 deals on record (3 funding rounds, 1 secondary share transfer), with disclosed funding of ₹272.33 Cr; the latest was in March 2025.
Rajesh Salwan was appointed as Additional Director on 18 Mar 2025. Uta Kellermann Renton was appointed as Additional Director on 18 Mar 2025. Kajal Palan ceased to be Additional Director on 23 Sep 2024. Apotex Research has 17 board changes on record in total.
Apotex Research has 12 MSME Form 1 returns on record between 2016 and 2024, listing 120 overdue payments to 50 micro and small suppliers. The latest return was filed on 23 Apr 2024.
Apotex Research can be reached through the website apotex.com. Its registered office is in Jigani Hobli, Karnataka, India.

